Greenwood Gearhart Inc. Sells 1,062 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Greenwood Gearhart Inc. reduced its position in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 59.4% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 725 shares of the healthcare conglomerate's stock after selling 1,062 shares during the quarter. Greenwood Gearhart Inc.'s holdings in UnitedHealth Group were worth $379,000 at the end of the most recent reporting period.

Several other large investors also recently modified their holdings of UNH. Brighton Jones LLC grew its stake in UnitedHealth Group by 176.2% during the fourth quarter. Brighton Jones LLC now owns 44,249 shares of the healthcare conglomerate's stock worth $22,384,000 after buying an additional 28,231 shares in the last quarter. Revolve Wealth Partners LLC boosted its stake in shares of UnitedHealth Group by 137.1% in the 4th quarter. Revolve Wealth Partners LLC now owns 4,019 shares of the healthcare conglomerate's stock valued at $2,033,000 after purchasing an additional 2,324 shares in the last quarter. Bank Pictet & Cie Europe AG raised its holdings in UnitedHealth Group by 3.9% in the 4th quarter. Bank Pictet & Cie Europe AG now owns 263,655 shares of the healthcare conglomerate's stock valued at $133,373,000 after buying an additional 9,872 shares during the last quarter. Hillsdale Investment Management Inc. raised its holdings in UnitedHealth Group by 27.4% in the 4th quarter. Hillsdale Investment Management Inc. now owns 744 shares of the healthcare conglomerate's stock valued at $376,000 after buying an additional 160 shares during the last quarter. Finally, Twin City Private Wealth LLC raised its holdings in UnitedHealth Group by 2.0% in the 4th quarter. Twin City Private Wealth LLC now owns 1,293 shares of the healthcare conglomerate's stock valued at $654,000 after buying an additional 25 shares during the last quarter. 87.86% of the stock is owned by institutional investors.

Insider Activity

In other news, Director Kristen Gil acquired 3,700 shares of the firm's stock in a transaction on Thursday, May 15th. The stock was acquired at an average price of $271.17 per share, for a total transaction of $1,003,329.00. Following the completion of the acquisition, the director owned 3,818 shares in the company, valued at $1,035,327.06. This trade represents a 3,135.59% increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Timothy Patrick Flynn purchased 1,533 shares of UnitedHealth Group stock in a transaction dated Wednesday, May 14th. The shares were bought at an average price of $320.80 per share, with a total value of $491,786.40. Following the completion of the acquisition, the director directly owned 6,033 shares of the company's stock, valued at approximately $1,935,386.40. This represents a 34.07% increase in their ownership of the stock. The disclosure for this purchase can be found here. In the last 90 days, insiders have bought 109,408 shares of company stock valued at $31,607,768. Corporate insiders own 0.28% of the company's stock.

Analysts Set New Price Targets

Several research analysts have issued reports on the stock. Royal Bank Of Canada lowered their price target on shares of UnitedHealth Group from $525.00 to $355.00 and set an "outperform" rating for the company in a report on Friday, May 16th. Deutsche Bank Aktiengesellschaft lowered their price target on shares of UnitedHealth Group from $521.00 to $362.00 and set a "buy" rating for the company in a report on Wednesday, May 14th. Oppenheimer lowered their price target on shares of UnitedHealth Group from $600.00 to $400.00 and set an "outperform" rating for the company in a report on Wednesday, May 14th. Barclays reissued an "overweight" rating on shares of UnitedHealth Group in a research report on Thursday, July 17th. Finally, Baird R W cut shares of UnitedHealth Group from a "strong-buy" rating to a "hold" rating in a research report on Wednesday, June 11th. One equities research analyst has rated the stock with a sell rating, nine have assigned a hold rating and fifteen have assigned a buy rating to the stock. According to MarketBeat, the stock presently has an average rating of "Moderate Buy" and an average target price of $394.43.

UnitedHealth Group Price Performance

Shares of UNH traded up $3.06 during midday trading on Tuesday, hitting $285.20. 14,233,925 shares of the company traded hands, compared to its average volume of 7,873,392. The company has a debt-to-equity ratio of 0.71, a current ratio of 0.85 and a quick ratio of 0.85. The stock has a 50-day moving average of $304.47 and a 200-day moving average of $432.39. The firm has a market cap of $258.72 billion, a P/E ratio of 11.94, a PEG ratio of 1.38 and a beta of 0.45. UnitedHealth Group Incorporated has a one year low of $248.88 and a one year high of $630.73.

UnitedHealth Group Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, June 24th. Shareholders of record on Monday, June 16th were given a dividend of $2.21 per share. This is a boost from UnitedHealth Group's previous quarterly dividend of $2.10. This represents a $8.84 dividend on an annualized basis and a yield of 3.10%. The ex-dividend date of this dividend was Monday, June 16th. UnitedHealth Group's dividend payout ratio (DPR) is presently 37.02%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.